Cabergoline
- Product NDC
- 69238-2693
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cabergoline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA218618
- Marketing category
- ANDA
- Substance
- CABERGOLINE
- Current FDA listing
- Yes
Related Records
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|---|---|---|---|---|
| 69238-2693-1 | 8 TABLET in 1 BOTTLE (69238-2693-1) | 2024-10-03 | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|---|---|---|---|
| Cabergoline Tablets, USP Rx only | A-S Medication Solutions | 2025-08-27 | HUMAN PRESCRIPTION DRUG LABEL | 1 |
| Cabergoline Tablets, USP Rx only | Amneal Pharmaceuticals NY LLC | 2024-10-03 | HUMAN PRESCRIPTION DRUG LABEL | 1 |